Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
GIPRs have been localized to human pancreatic -cells, and intravenous GIP infusion activates GIPR and intracellular signaling in pancreatic -cells, augmenting glucagonotropic effects in hypoglycemic conditions in humans (130)
It is a non-hormonal approach: no IGF-1 or cortisol changes, no stimulant jitters, no appetite suppression
Samit G, Binayak S
Instead of overwhelming the body with external hormones, it restores natural production patterns
Typical Protocol: Common research protocols use a loading phase of roughly 4-8 mg per week (split into 2-3 subcutaneous injections) for 4-6 weeks, followed by a maintenance phase of about 2-6 mg biweekly for another 4-8 weeks, with a full cycle running 8-14 weeks and at least 4 weeks off before repeating
Since GLP-1 antagonists slow digestion, they may worsen certain gastrointestinal conditions
US$ 26.89
US$ 29.48
US$ 22.94
US$ 20.28
